Summary:

- This article discusses the presentation of 12 new drug candidates at the American Chemical Society (ACS) National Meeting in San Diego. These drug candidates are in various stages of development and target a range of diseases, including cancer, Alzheimer's, and COVID-19.

- The article highlights the importance of the ACS National Meeting as a platform for researchers to showcase their latest discoveries and advancements in the field of drug development. It provides insights into the scientific process and the challenges researchers face in bringing new drugs to market.

- The article also emphasizes the potential impact these new drug candidates could have on improving human health and the quality of life for patients suffering from various diseases. It underscores the ongoing efforts of the scientific community to address unmet medical needs and drive innovation in the pharmaceutical industry.